{
  "retracted": false,
  "timestamp": 1580515200000,
  "updates": [
    {
      "timestamp": 1575049250252,
      "identifier": {
        "doi": "10.1016/j.breast.2019.11.010"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.breast.2018.08.033"
  },
  "journal": "The Breast",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies” [Breast 41S1 (2018) S11–12]"
}
